Ingevity falls 2.6% as basic materials sector weakens ahead of quarterly results

What happened

Ingevity (NGVT) fell 2.6% on October 7, 2026, as the basic materials sector weakened and the stock traded with above-average volume. The stock closed at $70.92 after opening 1.5% below the previous close. Trading volume was 1.2 times its 20-day average. The basic materials sector median fell 1.9% on the day while the S&P 500 fell 0.2%, suggesting the drop largely tracked sector-wide moves.

How big was the move

The stock's one-day change was 1.5 times a typical daily move for this stock, reflecting a stronger-than-normal intraday reaction. Ingevity's decline was 0.7 percentage points worse than the sector median, indicating the stock largely moved with its sector rather than on a clear company-specific catalyst. Market sensitivity, measured by a beta of 1.40, indicates the stock tends to move more than the market and likely amplified the day's drop. Over the last five sessions the stock rose 0.2%, while the S&P 500 rose 2.0% over the same period.

The technical picture

The stock traded 0.7% above its 20-day moving average and 0.7% above its 200-day moving average, while it was 0.9% below its 50-day moving average. The 50-day average is above the 200-day average, a sign of an established uptrend, and the stock has spent 12 consecutive trading days above the 200-day average. The Relative Strength Index (14 days) stood at 49, in the neutral range between 30 and 70. Ingevity finished the session 10.6% below the 52-week high. Shorter-term performance showed the stock rose 2.6% over one month and fell 1.8% over three months, and it rose 28.9% over one year, 13.2 percentage points ahead of the S&P 500. Volatility measured 28% annualized over 60 days, lower than 98% of its own readings over five years, pointing to relatively subdued price swings versus its historical norm.

Fundamentals and valuation

For the four quarters through June 30, 2026, Ingevity reported revenue of $1.16 billion, a decline of 12.4% from a year earlier. Diluted earnings per share for that period were $1.47, while gross margin improved to 41.1% from 36.5% a year earlier. Operating margin held near prior-year levels at 21.6% versus 21.8% a year earlier, and free-cash-flow margin was 13.3%. Return on invested capital was 12.3%. The balance sheet showed net debt of 5.9 times EBITDA, and share count over one year decreased by 2.2%.

Valuation metrics underline a gulf between price and recent results. The stock traded at 48.2 times trailing earnings, the highest reading of the past five years, compared with a five-year median of 16.7 times earnings. Price to forward earnings was 13.2 times expected earnings, and free-cash-flow yield was 6.2%. Market value at the session close was $2.49 billion. PromtFinance scores rank Ingevity with a Value score of 31 (Weak) and Growth 9 (Very weak), while Quality 86 (Strong) and Momentum 82 (Strong) reflect healthier operational metrics and recent price strength.

Earnings and analyst expectations

Ingevity said it would release third quarter 2026 results after the market close on Wednesday, November 4, 2026, and will host a webcast to discuss the release, according to Business Wire. The company last reported on July 29, 2026, with earnings per share of $1.74 against $1.33 expected, 30.8% above estimates. That marked two consecutive quarters beating estimates and an average surprise over the last four reports of 36.9% above estimates. Typical two-day reactions after recent reports were unchanged.

Thirteen analysts cover the stock. Seventy-seven percent assign a Buy rating and the consensus rating is Buy. The consensus price target was $71.50, 0.8% above the closing price on October 7, 2026.

What to watch

• November 4, 2026: Ingevity will release third quarter 2026 results after the market close and host a webcast.
• July 29, 2026: Last reported EPS of $1.74 against $1.33 expected, 30.8% above estimates.
• Consensus price target $71.50, 0.8% above the October 7, 2026, closing price.